The condensation of 1,1′-diaminoferrocene (1) with a range of chloroformamidinium salts [(R′RN) 2 CCl]X (2) afforded the corresponding bis(guanidines) [Fe{(η 5 -C 5 H 4 )−NC(NRR′) 2 } 2 ] (3; five examples). The two guanidine units present in 3 are able to chelate a proton or a water molecule. The structures of 3 and of the corresponding hydrates were determined by single-crystal X-ray diffraction. Cyclic voltammetry revealed that the ferrocene moiety of 3 is exceptionally electron rich, with E 1/2 values down to −0.90 V vs the ferrocenium/ ferrocene couple. According to the results of DFT calculations, these bis-(guanidines) are superbases with proton affinities considerably higher than that of the classic "Proton Sponge" 1,8-bis(dimethylamino)naphthalene. Furthermore, they are able to act as tridentate ligands, giving rise to Fe→M dative bonds, as is shown by chelates of the type [PdCl(3-κFe,κ 2 N)] + , which were obtained by reaction of 3 with [PdCl 2 (MeCN) 2 ]. The unusual N,Fe,N-chelating mode leads to exceptionally short Fe−Pd bonds (ca. 2.69 Å) and causes an enormous coordination-induced anodic shift of the half-wave potential of ca. 0.6 V.
Two homoleptic copper(I) complexes of the bidentate isocyanide 1,1′‐diisocyanoferrocene (1) were prepared and structurally characterised. The dications present in [Cu2(μ‐1)3][PF6]2 exhibit a paddle‐wheel‐like structure with trigonal‐planar CuI. These dications are connected in a chain‐like fashion by bridging ligands 1 in the coordination polymer [{Cu2(μ‐1)3}(μ‐1)]n(OTf)2n, which contains tetracoordinate CuI in a distorted tetrahedral coordination environment. The hexafluorophosphate analogue of the latter compound was also prepared.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.